Tumor grade was determined from primary and lymph node specimens and/or liver biopsies according to the Ki-67 proliferation index. We used the 2015 and 2017 WHO classification systems, respectively, for grading lung and gastro-enteropancreatic NENs [16,17]. We applied the Charlson comorbidity index to assess patients’ comorbidities [18]. For staging, we used the 8th edition of the American Joint Committee on Cancer (AJCC) [19]. Patients’ medications were monitored by dedicated specialists. To ensure the quality of data reporting, we followed the STROBE statement [20].

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.